PGIM India Healthcare Fund vs SBI Healthcare Opportunities Fund
Direct Plan, Growth option · Data as on 30-10-2026
PGIM India Healthcare Fund is a Thematic fund and SBI Healthcare Opportunities Fund is a Thematic fund. In the year to 30-10-2026, PGIM India Healthcare Fund (Direct) returned 18.1% and SBI Healthcare Opportunities Fund (Direct) returned 17.1%. PGIM India Healthcare Fund charges 0.98% a year and SBI Healthcare Opportunities Fund 1.01% (Direct plans). Their portfolios overlap 48.3%: they hold 17 of the same securities.
PGIM India Healthcare Fund
Thematic
- 1 year return
- 18.1%
- Expense ratio
- 0.98%
- NAV
- ₹12.10
SBI Healthcare Opportunities Fund
Thematic
- 1 year return
- 17.1%
- Expense ratio
- 1.01%
- NAV
- ₹588.16
Which is better, PGIM India Healthcare or SBI Healthcare Opportunities? Key differences
It depends on what you want from the fund. These are the differences in numbers, from the data on this page.
- PGIM India Healthcare returned more over 1 year: 18.1% against 17.1%.
- PGIM India Healthcare costs less: 0.98% a year against 1.01% (Direct plans).
- SBI Healthcare Opportunities fell less in its worst fall since 11-12-2024: −13.5% against −14.4%.
- SBI Healthcare Opportunities is the larger fund: ₹5,870 Cr against ₹130 Cr.
- Their portfolios overlap 48.3%: 17 of the same holdings.
Past returns do not promise future returns. This page is information, not investment advice.
Key facts
From each fund's scheme summary document and AMFI
| Fact | PGIM India Healthcare Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Fund house | PGIM India Mutual Fund | SBI Mutual Fund |
| Category | Thematic | Thematic |
| AUM | ₹130 Cr (30-09-2026) | ₹5,870 Cr (30-09-2026) |
| NAV | ₹12.10 (Direct) | ₹588.16 (Direct) |
| Expense ratio (Direct) | 0.98% | 1.01% |
| Expense ratio (Regular) | 2.65% | 1.99% |
| Riskometer | Very High | Not available |
| Benchmark | BSE Healthcare TRI | Not available |
| Launch date | 06-12-2024 | Not available |
| Minimum investment | ₹5,000 | Not available |
| Lock in | None | Not available |
| Fund managers | Anandha Padmanabhan Anjeneyan, Utsav Mehta, Vivek Sharma, and Mr. Puneet Pal | Not available |
| Exit load | Exit load of 0.50%, if redeemed within 90 days. | Not available |
PGIM India Healthcare vs SBI Healthcare Opportunities: Returns Comparison
Returns as on 30-10-2026. Up to one year they are absolute returns. Longer periods are a rate per year.
| Fund | 1M | 3M | 6M | 1Y | 3Y | 5Y | 10Y |
|---|---|---|---|---|---|---|---|
| PGIM India Healthcare Fund (Direct) | −1.22% | −1.14% | +15.90% | +18.05% | -- | -- | -- |
| SBI Healthcare Opportunities Fund (Direct) | +0.31% | −0.59% | +16.00% | +17.12% | +24.60% | +19.22% | +14.72% |
| Thematic average | −2.09% | −4.52% | +0.86% | −1.22% | +13.76% | +11.62% | +13.76% |
Category average: the average of the 235 Thematic funds, same plan type.
PGIM India Healthcare vs SBI Healthcare Opportunities: Year-wise Returns
| Year | PGIM India HealthcarePGIM India Healthcare | SBI Healthcare OpportunitiesSBI Healthcare Opportunities | BSE Healthcare TRI |
|---|---|---|---|
| 2026to date | +20.76% | +21.31% | +15.08% |
| 2025 | −0.99% | −2.50% | −2.72% |
| 2024 | -- | +43.75% | +44.30% |
| 2023 | -- | +39.72% | +37.97% |
| 2022 | -- | −5.01% | −11.50% |
| 2021 | -- | +21.48% | +21.54% |
PGIM India Healthcare vs SBI Healthcare Opportunities: Rolling Returns
Every holding period of both funds, against BSE Healthcare TRI, the benchmark of both
Rolling returns
Every 1-year holding period, 217 of them, one for each trading day from 11-12-2025 to 30-10-2026: the yearly return (CAGR) of each, plotted on the day it ended. One lucky or unlucky start day cannot flatter or hide a fund.
PGIM India Healthcare Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
BSE Healthcare TRI
to
Jan 2026Mar 2025
to
Mar 2026Apr 2025
to
Apr 2026Jun 2025
to
Jun 2026Aug 2025
to
Aug 2026Oct 2025
to
Oct 2026
How the periods spread
| Fund | Below 0% | 0-5% | 5-10% | 10-15% | 15-20% | 20-25% | Above 25% | Mean | Median | Lowest | Highest | Beat benchmark |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGIM India Healthcare | 9.2 | 13.8 | 11.1 | 21.2 | 22.1 | 12.0 | 10.6 | 13.1% | 13.8% | −3.0% | 29.3% | 97% |
| SBI Healthcare Opportunities | 14.1 | 12.7 | 15.9 | 22.7 | 17.7 | 16.4 | 0.5 | 10.7% | 11.4% | −3.3% | 25.3% | 68% |
| BSE Healthcare TRI | 13.8 | 14.3 | 20.7 | 36.4 | 14.7 | 0.0 | 0.0 | 8.7% | 10.2% | −3.7% | 19.5% | -- |
The table shows the % of periods in each return band; a darker cell holds more of them. Lumpsum: the yearly rate (CAGR) from a period's first NAV to its last. SIP: the XIRR of the monthly instalments. The benchmark is BSE Healthcare TRI, over the same periods. "Beat benchmark" counts the periods in which the fund did better. Every fund is measured over the days all of them have, from 11-12-2024. Past returns do not promise future returns.
PGIM India Healthcare vs SBI Healthcare Opportunities: SIP and Lumpsum Returns
What the same monthly or one-time investment would be worth in each fund today, from their own NAV history
Growth of an investment
₹10,000 on the first trading day of every month, from 11-12-2024 to 30-10-2026: 23 instalments, ₹2,30,000 in all.
| Investment | Invested | Value now | Gain | Return a year |
|---|---|---|---|---|
| PGIM India HealthcarePGIM India Healthcare Fund (Direct) | ₹2,30,000 | ₹2,72,424 | ₹42,424 | 18.1% |
| SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct) | ₹2,30,000 | ₹2,69,986 | ₹39,986 | 17.1% |
PGIM India HealthcarePGIM India Healthcare Fund (Direct)
SBI Healthcare OpportunitiesSBI Healthcare Opportunities Fund (Direct)
Amount invested
From each plan's published NAV (Growth option), over the same days. Return a year: XIRR for a SIP, CAGR for a lumpsum, shown for a year or more. It does not include exit load, stamp duty or tax. Past returns do not promise future returns.
PGIM India Healthcare vs SBI Healthcare Opportunities: Risk and Drawdowns
How much each fund swings, and the worst fall over the same days
Risk and return
| Measure | PGIM India Healthcare Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +18.05% | +17.12% |
| Standard deviation | 12.68% | 13.36% |
| Sharpe ratio | 1.01 | 0.89 |
| Sortino ratio | 1.50 | 1.33 |
| Maximum drawdown | −10.0% (23-10-2026) | −10.3% (23-10-2026) |
| Beta | 0.87 | 0.93 |
| Alpha | +6.61% | +5.25% |
From daily NAVs, 30-10-2025 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
| Measure | PGIM India Healthcare Fund (Direct) | SBI Healthcare Opportunities Fund (Direct) |
|---|---|---|
| Return (CAGR) | +10.77% | +17.93% |
| Standard deviation | 13.07% | 15.96% |
| Sharpe ratio | 0.40 | 0.74 |
| Sortino ratio | 0.54 | 1.05 |
| Maximum drawdown | −14.4% (28-02-2025) | −30.5% (23-03-2020) |
| Beta | 0.84 | 0.91 |
| Alpha | +3.79% | +3.97% |
From daily NAVs, 11-12-2024 to 30-10-2026. Standard deviation: how much the daily value swings, scaled to a year. Sharpe: return above the risk-free rate (NSE's overnight rate index) per unit of swing. Sortino: the same, counting only the falls. Beta and alpha compare each fund with its own benchmark's TRI.
Drawdowns
How far below its previous high each one was on every day: the falls an investor had to sit through. 0% means it was at a new high.
PGIM India Healthcare Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
BSE Healthcare TRI
| Fund | Worst fall | High before it | Bottom | Back at the high | Time to climb back | Below its high today |
|---|---|---|---|---|---|---|
| PGIM India Healthcare Fund (Direct) | −14.4% | 07-01-2025 | 28-02-2025 | 15-07-2025 | 5 months | −5.1% |
| SBI Healthcare Opportunities Fund (Direct) | −13.5% | 07-01-2025 | 28-02-2025 | 17-07-2025 | 5 months | −3.8% |
| BSE Healthcare TRI | −16.2% | 02-01-2025 | 28-02-2025 | 29-07-2025 | 5 months | −3.8% |
From daily values since 11-12-2024, the first day every fund has.
Rolling standard deviation
Whether the swings have grown or calmed over time: the standard deviation of daily changes over every 1-year window, scaled to a year, plotted on the window's last day. Higher means a bumpier ride.
PGIM India Healthcare Fund (Direct)
SBI Healthcare Opportunities Fund (Direct)
BSE Healthcare TRI
Against BSE Healthcare TRI
| Fund | Up capture | Down capture | Tracking error |
|---|---|---|---|
| PGIM India Healthcare Fund (Direct) | 110% | 95% | 3.86% |
| SBI Healthcare Opportunities Fund (Direct) | 100% | 86% | 3.80% |
From month-end values since 11-12-2024. Up capture: a fund's average month when the benchmark rose, as % of the benchmark's; above 100% it gained more. Down capture: the same for months the benchmark fell; below 100% it fell less. Tracking error: how far the monthly returns strayed from the benchmark's, a year; an index fund aims near 0.
PGIM India Healthcare vs SBI Healthcare Opportunities: Portfolio Overlap
From each fund's latest monthly portfolio: PGIM India Healthcare Fund, September 2026; SBI Healthcare Opportunities Fund, September 2026
Holdings in common
- Overlap
- 48.3%
- Held by both
- 17
- Only in PGIM India Healthcare
- 14
- Only in SBI Healthcare Opportunities
- 19
| Security | % of PGIM India Healthcare | % of SBI Healthcare Opportunities |
|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 10.25% | 11.14% |
| Divi's Laboratories Ltd. | 10.36% | 7.91% |
| Torrent Pharmaceuticals Ltd. | 8.49% | 4.42% |
| Max Healthcare Institute Ltd. | 4.71% | 3.80% |
| Aster DM Quality Care Ltd. | 2.56% | 3.21% |
| Sai Life Sciences Ltd | 2.54% | 2.60% |
| Cipla Ltd. | 2.04% | 4.40% |
| Anthem Biosciences Ltd. | 1.81% | 2.75% |
| Ajanta Pharma Ltd. | 4.96% | 1.79% |
| Mankind Pharma Ltd. | 4.04% | 1.71% |
| Krishna Inst of Medical Sciences Ltd. | 2.99% | 1.69% |
| Dr. Lal Path Labs Ltd. | 4.33% | 1.62% |
| Global Health Ltd. | 1.52% | 1.74% |
| Gland Pharma Ltd. | 1.50% | 2.96% |
| Jupiter Life Line Hospitals Ltd. | 1.46% | 2.16% |
| Fortis Healthcare Ltd. | 1.46% | 2.36% |
| Abbott India Ltd. | 3.12% | 0.23% |
Overlap: for each holding both funds own, the smaller of its two weights, added up. 48.3% means 48.3% of each fund's money sits in positions the other also holds. Matched by ISIN. Cash and hedged positions are left out.
Largest holdings only in PGIM India Healthcare Fund
| Security | % of fund |
|---|---|
| Manipal Health Enterprises Ltd. | 3.68% |
| Navin Fluorine International Ltd. | 3.24% |
| Rubicon Research Ltd. | 2.99% |
| Neuland Laboratories Ltd. | 2.91% |
| ICICI Lombard General Insurance Co. Ltd. | 2.10% |
Largest holdings only in SBI Healthcare Opportunities Fund
| Security | % of fund |
|---|---|
| Acutaas Chemicals Ltd. | 5.03% |
| Apollo Hospitals Enterprise Ltd. | 4.45% |
| Laurus Labs Ltd. | 4.05% |
| Aurobindo Pharma Ltd. | 3.42% |
| Sudeep Pharma Ltd. | 2.79% |
Asset and sector split
Share of each fund, from its latest monthly portfolio
Asset allocation
| Asset | PGIM India Healthcare | SBI Healthcare Opportunities |
|---|---|---|
| Equity | 94.9% | 95.5% |
| Debt | 0.0% | 0.1% |
| Cash and others | 5.1% | 4.4% |
Market cap of stocks
| Market cap | PGIM India Healthcare | SBI Healthcare Opportunities |
|---|---|---|
| Large Cap | 31.1% | 32.3% |
| Mid Cap | 31.6% | 25.7% |
| Small Cap | 25.1% | 35.4% |
| Not on AMFI's list | 7.0% | 2.2% |
Share of the whole fund. Groups follow AMFI's latest list: Large Cap is the 100 largest companies, Mid Cap the next 150, Small Cap the rest.
Largest sectors
| Sector | PGIM India Healthcare | SBI Healthcare Opportunities |
|---|---|---|
| Pharmaceuticals & Biotechnology | 62.8% | 63.1% |
| Healthcare Services | 24.6% | 25.6% |
| Chemicals & Petrochemicals | 3.2% | 5.0% |
| Insurance | 2.1% | 0.0% |
| Healthcare Equipment & Supplies | 0.8% | 1.8% |
| Retailing | 1.0% | 0.0% |
The six largest sectors of each fund's stocks, % of the fund.
PGIM India Healthcare vs SBI Healthcare Opportunities: Expense Ratio
What each plan charges a year, from AMFI's expense ratio file
| Charge | PGIM India Healthcare Fund | SBI Healthcare Opportunities Fund |
|---|---|---|
| Total expense ratio (Direct) | 0.98% | 1.01% |
| Base expense ratio (Direct) | 0.68% | 0.74% |
| Total expense ratio (Regular) | 2.65% | 1.99% |
| Base expense ratio (Regular) | 2.10% | 1.58% |
The expense ratio comes out of the fund's assets every day, so every return on this page is already after it. Base expense ratio: the fund house's own fee. The total adds brokerage, transaction costs, and levies with GST.
More comparisons
Each fund against the others of its category
Compare PGIM India Healthcare with
PGIM India Healthcare Fund vs SBI Healthcare Opportunities Fund: Frequently Asked Questions
What is the difference between PGIM India Healthcare Fund and SBI Healthcare Opportunities Fund?
PGIM India Healthcare Fund is a Thematic fund, SBI Healthcare Opportunities Fund is a Thematic fund, run by PGIM India Mutual Fund and SBI Mutual Fund. Their portfolios overlap 48.3%. PGIM India Healthcare Fund charges 0.98% a year and SBI Healthcare Opportunities Fund 1.01%.
Which has given higher returns, PGIM India Healthcare Fund or SBI Healthcare Opportunities Fund?
Over 1 year: PGIM India Healthcare Fund +18.05%, SBI Healthcare Opportunities Fund +17.12%. As on 30-10-2026. Past returns do not promise future returns.
Which has the lower expense ratio, PGIM India Healthcare Fund or SBI Healthcare Opportunities Fund?
PGIM India Healthcare Fund charges less: 0.98% a year against 1.01%. These are the Direct plans' total expense ratios reported to AMFI.
How much do PGIM India Healthcare Fund and SBI Healthcare Opportunities Fund overlap?
48.3%. They hold 17 of the same securities, the largest shared ones being SUNPHARMA, DIVISLAB, TORNTPHARM. From each fund's latest monthly portfolio.
Can I invest in both PGIM India Healthcare Fund and SBI Healthcare Opportunities Fund?
Yes. 48.3% of each fund's money sits in the same holdings, so a large part of the two investments would move together.
Sources: NAV and expense ratio from AMFI. Holdings from each fund house's monthly portfolio statement. Fund facts from each scheme summary document.
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.